The Journal of Cancer Research, Therapy and Perspectives (JCRTP) is an open access, peer-reviewed journal dedicated to advancing knowledge in cancer research, prevention, diagnosis, treatment, therapy and emerging perspectives in oncology.
Aims
JCRTP publishes rigorous, clearly reported work that improves the understanding, prevention and care of cancer. The journal connects laboratory, clinical and population research with practice, and welcomes contributions from all disciplines that work to reduce the burden of cancer.
Scope
Cancer biology and mechanisms
Molecular, cellular and genetic basis of cancer, tumour microenvironment, biomarkers and drug resistance.
Prevention and epidemiology
Risk factors, screening, early detection, cancer registries and population-based studies.
Diagnosis
Pathology, imaging, laboratory medicine, molecular diagnostics and staging.
Therapeutics
Surgery, radiotherapy, chemotherapy, targeted and immunotherapy, and treatment outcomes and toxicity.
Clinical research
Clinical studies and trials, outcomes research, and evidence that informs clinical practice and guidelines.
Translational research
Studies that move discoveries from the laboratory to patients, and clinical observations back to the laboratory.
Supportive and palliative care
Symptom management, survivorship, rehabilitation, quality of life and psycho-oncology.
Multidisciplinary perspectives
Oncology nursing and pharmacy, health services, policy, education, global oncology and digital health in cancer care.
Article types
- Original research articles: original findings from laboratory, clinical or population research.
- Review articles: critical, evidence-based reviews of important topics.
- Systematic reviews and meta-analyses: transparent, reproducible synthesis of evidence.
- Case reports: clinically significant cases, rare malignancies and unusual presentations.
- Clinical studies, short communications and scholarly perspectives are also considered.
Readership
JCRTP serves oncologists, surgeons, radiation and medical oncology teams, pathologists, nurses, pharmacists, researchers, educators and policymakers working in cancer research and care.
Open access
All published content is freely available to read online. Manuscripts outside the scope above may be declined at initial screening; authors are welcome to contact the editorial office before submitting if they are unsure. See the Author Guidelines to prepare a manuscript.
